Candriam SCA’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,546
Closed -$905K 905
2022
Q4
$905K Buy
+13,546
New +$905K 0.01% 714
2019
Q3
Sell
-24,045
Closed -$1.71M 781
2019
Q2
$1.71M Hold
24,045
0.02% 551
2019
Q1
$1.89M Hold
24,045
0.02% 512
2018
Q4
$2.04M Buy
+24,045
New +$2.04M 0.03% 459